Compton Wealth Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Sell |
1,764
-262
| -13% | -$106K | 0.18% | 57 |
|
|
2025
Q1 | $1.01M | Sell |
2,026
-112
| -5% | -$55.7K | 0.28% | 52 |
|
|
2024
Q4 | $1.11M | Buy |
2,138
+66
| +3% | +$34.3K | 0.29% | 54 |
|
|
2024
Q3 | $1.28M | Buy |
2,072
+28
| +1% | +$17.3K | 0.32% | 54 |
|
|
2024
Q2 | $1.13M | Buy |
2,044
+7
| +0.3% | +$3.87K | 0.3% | 54 |
|
|
2024
Q1 | $1.18M | Buy |
2,037
+22
| +1% | +$12.8K | 0.32% | 55 |
|
|
2023
Q4 | $1.07M | Buy |
2,015
+309
| +18% | +$164K | 0.34% | 51 |
|
|
2023
Q3 | $864K | Hold |
1,706
| – | – | 0.3% | 58 |
|
|
2023
Q2 | $890K | Sell |
1,706
-56
| -3% | -$29.2K | 0.3% | 57 |
|
|
2023
Q1 | $1.02M | Sell |
1,762
-11
| -0.6% | -$6.34K | 0.35% | 53 |
|
|
2022
Q4 | $976K | Sell |
1,773
-15
| -0.8% | -$8.26K | 0.38% | 53 |
|
|
2022
Q3 | $907K | Sell |
1,788
-7
| -0.4% | -$3.55K | 0.39% | 54 |
|
|
2022
Q2 | $975K | Buy |
1,795
+104
| +6% | +$56.5K | 0.42% | 53 |
|
|
2022
Q1 | $999K | Buy |
1,691
+120
| +8% | +$70.9K | 0.39% | 56 |
|
|
2021
Q4 | $1.05M | Buy |
1,571
+29
| +2% | +$19.3K | 0.45% | 52 |
|
|
2021
Q3 | $881K | Sell |
1,542
-28
| -2% | -$16K | 0.41% | 50 |
|
|
2021
Q2 | $792K | Buy |
1,570
+10
| +0.6% | +$5.05K | 0.37% | 51 |
|
|
2021
Q1 | $712K | Buy |
1,560
+708
| +83% | +$323K | 0.41% | 48 |
|
|
2020
Q4 | $397K | Buy |
+852
| New | +$397K | 0.25% | 63 |
|